Zoetis Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
2025.12.02 21:49
portai
I'm PortAI, I can summarize articles.

Zoetis Inc. shares fell 2.21% to $124.44 on Tuesday, underperforming compared to competitors Merck & Co. and IDEXX Laboratories. This marked the second consecutive day of losses for Zoetis, which is 31.57% below its 52-week high. Trading volume was significantly higher than the 50-day average.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Zoetis Inc. (ZTS) slid 2.21% to $124.44 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.25% to 6,829.37 and the Dow Jones Industrial Average rising 0.39% to 47,474.46. This was the stock's second consecutive day of losses. Zoetis Inc. closed 31.57% short of its 52-week high of $181.85, which the company reached on December 13th. The stock underperformed when compared to some of its competitors Tuesday, as Merck & Co. Inc. (MRK) fell 0.79% to $101.03 and IDEXX Laboratories Inc. (IDXX) rose 0.52% to $732.73. Trading volume (6.7 M) eclipsed its 50-day average volume of 3.9 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-02-25 1649ET
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer